glp-1 for ckd Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor advanced glycation end products–induced inflammation TrimRX | Custom GLP-1 Dosing
Description
Compounded options allow for dose flexibility and cost reductionPlexusDx compounded semaglutide starts at $149 per monthmaking treatment accessible without reliance on insurance coverage or membership fees
Electrolyte drink mixes
Practical Diabetes 37(5):194195
On the clinician side, clinicians need to be informed and become competent in this area
It could also suppress their appetite, making it even harder for them to get the nutrients they need
Patients with type 2 diabetes, especially those with cardiovascular disease, chronic kidney disease, obesity, or NAFLD, may benefit from GLP-1 receptor agonists as part of their treatment regimen
